Ankle Syndesmosis Treatment Devices Market by Product (Syndesmosis Implant Systems, Syndesmosis Plate Kits and Syndesmosis Clamps)
Industry: Healthcare
Published Date: March-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 264
Report ID: PMRREP29971
The Global revenue from the Ankle Syndesmosis Treatment Devices Market was around US$ 157.1 Million in 2022, with the global market expected to grow at a CAGR of 7.7% to reach a valuation of around US$ 355.2 Million by the end of 2033.
|
Market Size (2023) |
US$ 169.3 Million |
|
Projected Market Value (2033) |
US$ 355.2 Million |
|
Global Market Growth Rate (2023 to 2033) |
7.7% CAGR |
|
Market Share of Top 5 Countries |
62.5% |
As analysed by Persistence Market Research, the product segment Syndesmosis Implant systems held a market share of around 53.2% in the global market, in 2022. Overall, ankle syndesmosis treatment market sales account for around 4.0% of revenue share in the global foot and ankle devices market, which was valued at around US$ 3.9 Billion in 2022.
The global market recorded a historic CAGR of 7.2% in the last 8 years from 2014 to 2022.
Leading market players are prioritising product innovations by increasing their research and development spending and carrying out research. Product portfolio expansion is crucial for the business's ability to increase revenue and capture market share.
The manufacturers can get a competitive edge by creating novel lower extremity implants and releasing them in the market. This supports research and development efforts and grows the business.
Now that businesses are concentrating on product creation, implementing new product development methods, and carrying out rigorous quality control checks, technologically improved fracture repair solutions are gaining ground. Acquisitions help businesses broaden their geographic reach, meet unmet medical needs of the local patient population, and increase their product offerings. Acquisitions also assist in lowering market entry barriers. Through acquisitions, the business can access new markets and product lines with well-known brands already established.
The main tactic used by market participants to maintain their market share growth is the introduction of new products. It is anticipated that increased research and development efforts and investments in product innovation will stimulate firms to introduce new products. The willingness of surgeons to perform technologically advanced surgeries, increased awareness of metal and absorbable implants, and expanding access to personalised therapies in the age of personalised medicine have all contributed to an increase in the adoption of recently introduced orthopaedic implants.
Key goals of surgeons are to enhance patient outcomes and hasten rehabilitation. Higher coverage for foot and ankle implants is also likely to promote adoption and raise the likelihood that the surgeon may suggest these implants.
The global market is likely to show high growth over the coming years at a CAGR of 7.7% and reach a global market size of US$ 355.2 Million by 2033.
“Increase in Incidence and Prevalence of Sport Injuries and Fractures”
In the forecast period, demand for ankle syndesmosis treatment devices is expected to increase due to an increase in accidents and bone disorders like joint pain, instability in the joint, bone loss, and infection. The use of foot and ankle implants for a variety of reasons, fractures, and support injuries has been revolutionised by recent technological breakthroughs and the use of innovative implant materials.
The growing awareness among surgeons of the benefits of these implant materials has led to an increase in the use of titanium and biodegradable implants for fracture repair. Implants made of titanium are lightweight and maintain a steel-like level of strength. Using bioabsorbable implants has a number of benefits, including minimal risk of osteopenia, no irritation of soft tissue, and no need for a second procedure to remove the implants.
The most frequent injuries among athletes and sportspeople are ankle fractures and syndesmotic injuries. Ankle sprains and injuries benefit from early diagnosis and treatment since it promotes faster healing and lessens pain. The market is anticipated to grow as more health care providers concentrate on the best treatment for ankle injuries.
The fundamental idea of anatomic reduction of the ankle joint and secure anatomic fixation of distal tibiofibular joint underlies all surgical therapies for syndesmotic injuries. In order to minimise patient discomfort, appropriate stabilisation should be ensured, to promote a quick recovery from sports injuries.
Fractures of the foot and ankle have an impact on the patient's finances as well as the health care system's finances. Treatment for patient's foot and ankle problems comes at a large direct and indirect expense. In the forecast period, an increase in the financial burden of fractures is anticipated to fuel the worldwide ankle syndesmosis market.
“Product Recall in Foot and Ankle Market”
Sales of foot and ankle implants are impacted when products are recalled due to manufacturing flaws, side effects, bone loss, or infection. Several arthroplasty device manufacturers have had their products recalled by regulatory bodies such the Food and Drug Administration. Additionally, some producers of products made voluntary recalls.
Syndesmosis implants may cause a number of issues, and the patient may need to have another surgery to have the implant removed. This results in a financial burden and an overuse of medical services.
Why is the United States Market Booming?
“Government Initiatives and Strengthening Research and Development in Emerging Markets”
The United States accounted for around 39.1% market share in the global market in 2022.
The United States dominates the global ankle syndesmosis treatment devices market globally. As more new players in the ankle syndesmosis treatment devices market begin to commercialise these implants, their application in fracture fixation is growing. United States Manufacturers have created a variety of copolymers, biodegradable polymers, and composites to replace metal implants for internal fracture fixation.
The number of domestic companies conducting research and development, novel products and drugs approval, increasing number of upcoming market players within the United States, growing research and development by domestic companies, and the amount of funding for the development of novel technologies have played a major role in the market growth.
Will the Germany Be a Lucrative Market for Ankle Syndesmosis Treatment Devices?
“Need for Revised Regulations, and Presence of Strong Market Player”
The Germany market held around 7.0% market share of the global market in 2022.
The lateral ankle sprain (LAS) is one of the common injuries in everyday sports activities. The increase number of accidents and bone disorder are the key factors imparting growth to the market. Also, different governmental regulations to support the sports players are increasing in Germany which makes it a prominent player in the global market.
How is China Emerging as a Prominent Market?
“Focus on Development of Innovative Solutions and Business Plans”
China held a market share of about 5.6% of the global market in 2022.
China has been developing cell therapies for many years and could offer some novel treatments. There has been an increase in demand of lower extremities implants by the emerging markets. The focus of the country on developing and commercializing implants in its key growth segments along with the rise in necessary funding by government to continue operations, and the medical insurance policy contributes in growth of global ankle syndesmosis treatment devices market.
Which Product is Driving Demand within the Global Market?
“Product Launch and Portfolio Expansion”
The Syndesmosis Implant Systems product segment held around 53.2% share of the global market in 2022.
The syndesmosis implants systems held the largest share in the global market, owing to increase in demand for titanium-based implants and products portfolio expansion by key market players. Additionally, adoption and advancement in biodegradable implants in facture fixation is increasing along with the commercialization of key market players in ankle syndesmosis treatment market. These biodegradable implants are the good substitute for metal implants used for internal fracture fixation.
Which Application is Largely Adopted within the Global Market?
“Interaction with Diverse Monoaminergic Targets”
The ankle fractures held around 54.8% share of the total market in 2022.
Increasing number of footfalls, road accidents, and bone disorder leads the growth of global market of ankle fracture. It is one of the leading application segments, owing to increase in prevalence of ankle fractures and rise in awareness about surgical treatment.
Which End User Propels the Global Sales in the Market?
“Safety and Quality Maintenance in Accordance to Regulations”
The hospitals held a share of about 46.3% in 2022, within the global market.
A significant portion of this segment can be attributed to the large patient population, preference for hospitals, growing volume of procedures performed in hospital settings, rising number of hospital admissions, growing emphasis on accurate and early disease diagnosis in hospitals, and high budgets allocated by hospitals for the introduction of various technologically advanced foot and ankle device products. The increasing demand for minimally invasive surgeries can also contribute to the growth of the hospital segment.
Mergers and acquisitions to develop a strong market position, establishing solid, direct customer relationships, increasing access to premium items, and creating a portfolio that targets people in the middle of the economic spectrum, are some reasons for the growth of the market. The acquisition allows the companies to expand its offering of products for the extremities.
With the acquisition, the business gained access to cutting-edge technologies for foot and ankle surgeries. Similar strategic activities are being done by other companies like expansion of their business portfolio .
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the ankle syndesmosis treatment devices market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2014 to 2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global ankle syndesmosis treatment devices market is currently valued at around US$ 157.1 Million in 2022.
The global market estimates for 2023 is US$ 169.3 Million.
The global market is set to reach valuation of US$ 355.2 Million by the end of 2033.
Sales of the market are set to witness growth at a CAGR of 7.7% between 2023 and 2033.
Demand for the global market increased at a 7.2% CAGR from 2014 to 2022.
The U.S., China, Germany, the U.K., and Japan account for most demand within the market, currently holding around 62.5% market share.
The U.S. accounts for around 39.1% share of the global ankle syndesmosis treatment devices market in 2022.
The China market held a share of about 5.6% in the global ankle syndesmosis treatment devices market in 2022.
The Germany ankle syndesmosis treatment devices market holds the share of 7.0% globally in 2022.
Arthrex, Inc., Mortise Medical, Smith & Nephew Plc., Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Exactech, Inc., Acumed LLC, Inion Oy, Mortise Medical and Paragon 28, Inc. are the key players driving the global market.
